Exercise Intervention as Treatment for People Using Cannabis (ExIT-C)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-40
SponsorThe University of Hong Kong

About this trial

In Hong Kong, although the total number of drug abusers is trending down in recent years, the number of cannabis users continues to surge. The misuse of cannabis, if left unattended, predisposes various degrees of dependence and use disorders, which could later on induce psychotic disorders and schizophrenia. Effective strategies combating cannabis dependence and cannabis use disorder (CUD) are therefore warranted.

Exercise presents as a low-cost and low-stigma alternative to traditional pharmacotherapy and psychotherapy in the treatment of substance use disorders, which also promotes physical well-being with virtually no side effects. While exercise has some success in treating use disorders of stimulants, alcohol, and tobacco, evidence of its effects on CUD remains scarce. Hence, the present study will be conducted to assess the effectiveness of a 12-week aerobic exercise training regimen on reducing cannabis dependence and the severity of CUD.

Participants with cannabis dependence will be randomly assigned to either the exercise or the control group. Participants assigned to the exercise group will partake in a 12-week aerobic exercise training program of vigorous-intensity using indoor bikes, whereas those assigned to the control group will perform sham exercise of very light-intensity on indoor bikes. The 12-week study is divided into three (3) 4-week phases:

1. Intensive Intervention - all participants will exercise twice a week under supervision. 2. Active Intervention - all participants will exercise once a week under supervision. 3. Passive Maintenance - no supervised exercise sessions will be provided. All participants will receive exercise reminders via weekly text messages.

Cannabis use-related, cognitive, and physical outcomes will be assessed every 4 weeks, whereas withdrawal symptoms will be assessed and urine quick test administered every week.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Young adults of 18-40 years old

Able to read and communicate in English and/or Chinese

Able to give informed consent

Using cannabis or marijuana as the primary psychoactive substance of abuse

Disqualifiers

Age < 18 or > 40 years old

Unable to read English or Chinese

Unable to give informed consent

Absolute and/or relative contraindications to exercise training as indicated by the Physical Activity Readiness Questionnaire for Everyone (PAR-Q+) and the electronic Physical Activity Readiness Medical Examination (ePARmed-X+)

Trial design

Design model

Parallel

Treatments tested in this trial

  • Indoor Cycling

    Behavioral

    Indoor cycling at 60-70% HR reserve for 30 minutes.

  • Indoor Cycling

    Behavioral

    Indoor cycling at 20-30% HR reserve for 30 minutes.

Treatment groups

60 Participants
are divided into 2 treatment groups
Group A: Exercise Intervention Treatment (ExIT) GroupExperimental treatment 1 intervention
Group B: Sham-exercise Control (SCN) GroupSham comparator 1 intervention

Trial outcomes

Primary outcomes

1

Clinical Diagnosis of Cannabis Use Disorder (CUD)

Structured Clinical Interview for DSM-5 Disorders (SCID-5) is used to ascertain the diagnosis and severity of CUD

Time frame
At enrollment and 4, 8, and 12 weeks after enrollment
2

Psychological Dependence on Cannabis

Severity of Dependence Scale (SDS) is used to assess psychological dependence on cannabis

Time frame
At enrollment and 4, 8, and 12 weeks after enrollment

Secondary outcomes

1

Urine Toxicology Test

Drug of Abuse Urine Test Kits is used to ascertain recent use of cannabis and/or other substances

Time frame
At enrollment and 1, 2, 3, 4, 5, 6, 7, 8, and 12 weeks after enrollment
2

Cannabis Craving

Marijuana Craving Questionnaire - Short Form (MCQ-SF) is used to assess cannabis craving

Time frame
At enrollment and 4, 8, and 12 weeks after enrollment
3

Cannabis Problems

Cannabis Problems Questionnaire (CPQ) is used to assess cannabis-related problems

Time frame
At enrollment and 4, 8, and 12 weeks after enrollment
4

Cannabis Withdrawal

Cannabis Withdrawal Scale (CWS) is used to assess cannabis withdrawal symptoms

Time frame
At enrollment and 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, and 12 weeks after enrollment

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.